No Data
Germany Syringe Market Forecasts Report 2024: A $489.4 Million Market by 2029 Featuring Major Players - BD, B. Braun Melsungen, Terumo, Teleflex, Nipro, ICU Medical, and Cardinal Health
Express News | Citigroup Maintains Neutral on Cardinal Health, Lowers Price Target to $107
Cardinal Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/19/2024 11.95% Citigroup $115 → $107 Maintains Neutral 07/09/2024 9.86% Evercore ISI Group $115 → $105
Cardinal Health (NYSE:CAH) Shareholders Have Earned a 20% CAGR Over the Last Five Years
Cardinal Health, Inc. (NYSE:CAH) shareholders might be concerned after seeing the share price drop 12% in the last quarter. But that doesn't change the fact that the returns over the last five
Citigroup Adjusts Price Target on Cardinal Health to $107 From $115, Neutral Rating Maintained
Cardinal Health (CAH) has an average hold rating and a price target range of $92 to $130, according to analysts polled by Capital IQ.
Citi Maintains Cardinal Health(CAH.US) With Hold Rating, Cuts Target Price to $107
Citi analyst Daniel Grosslight maintains $Cardinal Health(CAH.US)$ with a hold rating, and adjusts the target price from $111 to $107.According to TipRanks data, the analyst has a success rate of 50.4